info@seagull-health.com

SeagullHealth

语言:

Homepage

Drugs

Sandostatin(Octreotide Acetate Injection)

Names

BYNFEZIA, 善龙,醋酸奥曲肽注射液,善宁,奥曲肽注射液

Indicatons

Acromegaly patients who cannot achieve adequate results from surgery or radiation therapy.

Price:

Manufacturer:

Novartis

Dosage form:

INJECTION

Validity period:

Reminder: The outer packaging is for reference only, please purchase and use under the guidance of a pharmacist. For read by medical and pharmaceutical professionals only.

Sandostatin(Octreotide Acetate Injection) Instructions:Uses,Dosage, Side Effects

BYNFEZIA PEN (octreotide acetate) is a somatostatin analogue used primarily for the treatment of hormone-related conditions, including acromegaly and certain types of tumors such as metastatic carcinoid and VIPomas. It works by inhibiting excessive secretion of growth hormone and other hormones, alleviating symptoms like flushing and diarrhea. The drug is administered via subcutaneous injection, which for patient self-administration.

BYNFEZIA PEN provides a critical management option for patients who have not responded well to surgery, irradiation, or other pharmacological treatments. It is a versatile and effective therapeutic tool in the management of these complex endocrine and gastrointestinal disorders.

Generic name

Sandostatin(Octreotide Acetate Injection)

English name

Octreotide Acetate Injection

Alternative Names

BYNFEZIA, 善龙,醋酸奥曲肽注射液,善宁,奥曲肽注射液

Drug prices

Indications

1. Acromegaly: To reduce elevated levels of growth hormone (GH) and insulin-like growth factor-1 (IGF-1) in patients who are unresponsive to or ineligible for surgical resection, pituitary irradiation, or bromocriptine mesylate.

2. Metastatic Carcinoid Tumors: For symptomatic treatment of severe diarrhea and flushing episodes.

3. Vasoactive Intestinal Peptide Tumors (VIPomas): For the management of profuse watery diarrhea associated with VIP-secreting tumors.

Therapeutic Target

Somatostatin receptors in the endocrine and neuroendocrine systems, particularly in pituitary and gastrointestinal tract cells secreting GH, VIP, and other peptides.

Active Ingredients

Octreotide acetate (synthetic somatostatin analog)

Dosage Form

INJECTION

Specifications

30mg*1vial/box

Dosage and Administration

Route: Subcutaneous injection into the abdomen, upper outer arm, or front of thighs; rotate injection sites.Administer at room temperature. Visually inspect for clarity and absence of particles.

1. Acromegaly: Initial dose: 50 mcg three times daily for 2 weeks; maintenance: 100–500 mcg three times daily.

2. Carcinoid Tumors: 100–600 mcg daily in 2–4 divided doses.

3. VIPomas: 200–300 mcg daily in 2–4 divided doses.

Related Columns

Recommended articles

What are the side effects of Sandostatin?

Sandostatin is a biological agent for the treatment of diseases such as acromegaly. It can effectively inhibit hormone levels, delay tumor growth, improve preoperative indicators, reduce or elimi...

Sandostatin treatment effect

Sandostatin is a freeze-dried powder injection of white or off-white powder, the main ingredient of which is octreotide. Other aliases include SANDOSTATIN LAR, Octreotide Acetate Injection, Octreotide...

Sandostatin LAR Dosage and Administration

The dosage and administration of SANDOSTATIN LAR needs to be customized by the doctor according to the patient's specific situation. Generally, SANDOSTATIN LAR needs to be injected at the prescrib...

What are the precautions for using Sandostatin?

Sandostatin is suitable for adult patients with acromegaly, carcinoid, and VIP tumors. If the indications are met, you can consult a doctor whether to use the drug. Although Sandostatin is e...

SANDOSTATIN Instructions

SANDOSTATIN LAR is a prescription drug with octreotide as its main ingredient. It is used to treat some endocrine diseases, such as acromegaly and carcinoid syndrome. Currently, SANDOSTATIN LAR has be...

What is Sandostatin?

Sandostatin is also known as SANDOSTATIN LAR, Octreotide Acetate Injection, Octreotide Acetate Injection, and Octreotide. Many patients who are not familiar with drugs are unfamiliar with Sandostatin....

Departments